Pascal Verdié, a chemical engineer from the École Nationale Supérieure de Chimie of Montpellier, France, performed a PhD program in Chemistry and Biology Sciences for Health, Montpellier University, which he graduated from in 2005. He worked on the development of selective ligands for the α-MSH MC1 receptor by the means of a huge program of peptide and combinatorial chemistry. Pascal received a Research Associate position at Montpellier University since 2005. He is in charge of the SynBio3 platform dedicated to assist the development of research programs in life science providing biomolecules and polymers of biological and pharmaceutical interest. He has succeeded in obtaining the IBISA label since January 2013 and in achieving ISO 9001 certification in 2015.